Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson's disease

被引:51
|
作者
Blesa, Javier [1 ,2 ]
Juri, Carlos [1 ,3 ]
Garcia-Cabezas, Miguel A. [4 ,5 ]
Adanez, Rebeca [1 ,2 ]
Sanchez-Gonzalez, Miguel A. [4 ,5 ]
Cavada, Carmen [4 ,5 ]
Obeso, Jose A. [1 ,2 ]
机构
[1] Clin Univ Navarra, Ctr Invest Med Aplicada, Dept Neurol & Neurociugia, Lab Trastornos Movimiento,Neurociencias, Pamplona, Spain
[2] Inst Carlos III, Minist Ciencia & Innovat, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[3] Pontificia Univ Catolica Chile, Dept Neurol, Santiago, Chile
[4] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain
[5] Inst Invest Sanitaria IdiPAZ, Madrid, Spain
来源
FRONTIERS IN SYSTEMS NEUROSCIENCE | 2011年 / 5卷
关键词
MPTP; Parkinson's disease; PET; dopaminergic; F-18-DOPA; compensatory mechanisms;
D O I
10.3389/fnsys.2011.00092
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The onset of Parkinson's disease (PD) is characterized by focal motor features in one body part, which are usually correlated with greater dopaminergic depletion in the contralateral posterior putamen. The role of dopamine (DA) hemispheric differences in the onset and progression of motor symptoms of PD, however, remains undefined. Previous studies have demonstrated that unilateral manipulations of one nigrostriatal system affect contralateral DA turnover, indicating a functional and compensatory inter-dependence of the two nigrostriatal systems. In preliminary data obtained by our group from asymmetric PD patients, a higher asymmetry index as measured by 6-[F-18]fluoro-L-dopa (F-18-DOPA) positron emission tomography (PET) was associated with a higher threshold (i.e., greater dopaminergic loss) for the onset of motor symptoms in the less-affected side. To further elucidate the underlying basis for this, we carried out a complementary study in monkeys using PET to assess and correlate the degree of dopaminergic striatal depletion with motor activity. Control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated monkeys with symmetrical lesions were characterized behaviorally and with F-18-DOPA PET. In parallel, an acute lesion was inflicted in the nigrostriatal projection unilaterally in one monkey, generating a 30% dopaminergic depletion in the ipsilateral striatum, which was not associated with any noticeable parkinsonian feature or deficit. The monkey remained asymptomatic for several months. Subsequently, this monkey received systemic MPTP, following which motor behavior and PET were repeatedly evaluated during progression of parkinsonian signs. The brains of all monkeys were processed using immunohistochemical methods. Our results suggest that the onset of motor signs is related to and influenced by the dopaminergic status of the less-affected, contralateral striatum. Although this work is still preliminary, the study agrees with our general hypothesis of hemispheric inter-dependence in the compensation of striatal DA deficit in PD
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Cholinergic and Dopaminergic Alterations in Nigrostriatal Neurons Are Involved in Environmental Enrichment Motor Protection in a Mouse Model of Parkinson’s Disease
    Willyan Franco Hilario
    Alice Laschuk Herlinger
    Lorena Bianchine Areal
    Lívia Silveira de Moraes
    Tamara Andrea Alarcon Ferreira
    Tassiane Emanuelle Servane Andrade
    Cristina Martins-Silva
    Rita Gomes Wanderley Pires
    Journal of Molecular Neuroscience, 2016, 60 : 453 - 464
  • [42] Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease
    Leem, Eunju
    Nam, Jin Han
    Jeon, Min-Tae
    Shin, Won-Ho
    Won, So-Yoon
    Park, Sang-Joon
    Choi, Myung-Sook
    Jin, Byung Kwan
    Jung, Un Ju
    Kim, Sang Ryong
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2014, 25 (07) : 801 - 806
  • [43] Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease
    Kim, Mia
    Cho, Ki-Ho
    Shin, Mal-Soon
    Lee, Jae-Min
    Cho, Han-Sam
    Kim, Chang-Ju
    Shin, Dong-Hoon
    Yang, Hyeon Jeong
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 33 (04) : 870 - 878
  • [44] Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: Comparisons with Parkinson's disease
    Piggott, MA
    Perry, EK
    Marshall, EF
    McKeith, IG
    Johnson, M
    Melrose, HL
    Court, JA
    Lloyd, S
    Fairbairn, A
    Brown, A
    Thompson, P
    Perry, RH
    BIOLOGICAL PSYCHIATRY, 1998, 44 (08) : 765 - 774
  • [45] Detection of the latent functional insufficiency of dopaminergic neurons in the nigrostriatal system in a chronic model of Parkinson’s disease
    V. V. Safandeev
    A. A. Kolacheva
    D. E. Ivanov
    M. V. Ugryumov
    Neurochemical Journal, 2017, 11 : 290 - 295
  • [46] Growth/differentiation factor 5 protects nigrostriatal dopaminergic neurones in a rat model of Parkinson's disease
    Sullivan, AM
    OpackaJuffry, J
    Hotten, G
    Pohl, J
    Blunt, SB
    NEUROSCIENCE LETTERS, 1997, 233 (2-3) : 73 - 76
  • [47] Changes in the Content of Sphingolipids in the Nigrostriatal Dopaminergic System in the Brain of Mice with a Neurotoxic Model of Parkinson's Disease
    Alessenko, A., V
    Blokhin, V. E.
    Shupik, M. A.
    Gutner, U. A.
    Lebedev, A. T.
    Maloshitskaya, O. A.
    Sokolov, S. A.
    Ugrumov, M., V
    NEUROCHEMICAL JOURNAL, 2021, 15 (02) : 175 - 180
  • [48] A New Approach to Assessing the Extent of Degradation of the Nigrostriatal Dopaminergic System in an Experimental Model of Parkinson’s Disease
    Safandeev V.V.
    Ugrumov M.V.
    Neuroscience and Behavioral Physiology, 2020, 50 (4) : 451 - 458
  • [49] Changes in the Content of Sphingolipids in the Nigrostriatal Dopaminergic System in the Brain of Mice with a Neurotoxic Model of Parkinson’s Disease
    A. V. Alessenko
    V. E. Blokhin
    M. A. Shupik
    U. A. Gutner
    A. T. Lebedev
    O. A. Maloshitskaya
    S. A. Sokolov
    M. V. Ugrumov
    Neurochemical Journal, 2021, 15 : 175 - 180
  • [50] Degeneration of nigrostriatal dopaminergic neurons in the early to intermediate stage of dementia with Lewy bodies and Parkinson's disease
    Okitsu, Masato
    Sugaya, Keizo
    Nakata, Yasuhiro
    Kawazoe, Tomoya
    Ikezawa, Jun
    Okiyama, Ryoichi
    Takahashi, Kazushi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 449